HR 6897
118th Congress
House
Health
Synthetic Biology and Active Pharmaceutical Ingredients Act
Introduced: December 22, 2023
Introduced by:
Slotkin, Elissa
Democratic
· Michigan
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 22, 2023
Referred to the House Committee on Armed Services.
Dec 22, 2023
Introduced in House
Plain-English summary
Synthetic Biology and Active Pharmaceutical Ingredients Act
This bill requires the Department of Defense (DOD) to establish a pilot program to support domestic manufacturing of critical pharmaceutical ingredients and their components through certain novel technology.
Specifically, DOD must establish a three-year program that uses technology involving synthetic biology to support domestic manufacturing of pharmaceutical ingredients and related incorporated materials that (1) are not available in a sufficient quantity or quality domestically, and (2) are strategically important to the United States.
What's happening now
Referred to the House Committee on Armed Services.
Committees of jurisdiction
1